7Du-Hu Liu Xue-Yong Zhang Dai-Ming Fan Yu-Xin Huang Jin-Shan Zhang Wei-Quan Huang Yuan-Qiang Zhang Qing-Sheng Huang Wen-Yu Ma Yu-Bo Chai Ming Jin Institute of Digestive Disease,Xijing Hospital,~2 Department of Gastroenterology,Tangdu Hospital,~3Department of Histology and Embryology,~4 Department of Microbiology,~5 Department of Biochemistry,Fourth Military Medical University,Xi’an 710033,Shaanxi Province,China.Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma[J].World Journal of Gastroenterology,2001,7(4):500-505. 被引量:37
6Akuta N , Kumada H. Influence of hepatitis B virus genotypes on the response to antiviral therapies[J].J Antimicrob Chemother. 2005 ; 55 : 13921421
7Thursz M. Genetic susceptibility in chronic viral hepatitis[J] . Antiviral Res. 2001 ;52:11321161
8Nakoo K, Nakata K, Yamashita M , et al. P48 ( ISGF- 3gamma) is involved in interferon-alpha induced suppression of hepatitis B virus enhancer- 1 activity[J] .J Biol Chem, 1999 , 274(40) : 28075.
9Radecke K, Protzer U, Trippler M, et al. Selection of hepatitis B virus variants with aminoacid substitutions inside the the core antigen during interferon-alpha therapy[J] . J Med Virol 2000; 62:479 - 486
10Zampino R, Marrone A, Cirillo G, del Giudice EM, et al. Sequential analysis of hepatitis B virus rare promoter and precore in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment[J] .J Viral Hepat. 2002; 9: 183- 188.